You have horrible timing Stoney
You hated it when I said buy it at $276 and hence you missed that meteoric run to north of $330... now you like it and it tanks.
Stick with VZ Stoney.
Buy Wally World @$140
GBA Presents: RADIO SAVANT-!
- Thread starter stonedinvestor
- Start date
You hated it when I said buy it at $276 and hence you missed that meteoric run to north of $330... now you like it and it tanks.
Stick with VZ Stoney.
Buy Wally World @$140
Good Morning GM---
Watching Home Depot today for entry.- THE OPTION KING
(have not read report yet)
Caesars shares can more than double from here, says B. Riley
Whoo hoo! I've been thinking about Ceasars too they had a big screw up recently with TwinSpires- a division and super bowl betting.
FOCUS STOCK-
Harmony Biosciences reports Q4 non-GAAP EPS $1.01, consensus 58c 07:33 HRMY
I've been circling Harmony for almost two months.
B.S.AIPR Of The Day- DPRO
Oh it hurts when it's a name you love.
Draganfly to showcase drone, AI technology at World Police Summit 07:30 DPRO
DigitalOcean price target raised to $46 from $40 at Canaccord 07:28 DOCN
Generac downgraded to Neutral from Buy at Janney Montgomery Scott » 07:13 GNRC
Generac downgraded to Short Me from Hold at gummybear advisors
Generac downgraded to Hold from Buy at Truist 06:59 GNRC
Walmart: December was largest U.S. sales volume month in history
BioCryst sees 2023 ORLADEYO revenue no less than $320M 07:08 BCRX
Wells cuts SentinelOne to Equal Weight on concerns of declining demand trends » 06:50 S
Watching Home Depot today for entry.- THE OPTION KING
(have not read report yet)
Caesars shares can more than double from here, says B. Riley
Whoo hoo! I've been thinking about Ceasars too they had a big screw up recently with TwinSpires- a division and super bowl betting.
FOCUS STOCK-
Harmony Biosciences reports Q4 non-GAAP EPS $1.01, consensus 58c 07:33 HRMY
I've been circling Harmony for almost two months.
B.S.AIPR Of The Day- DPRO
Oh it hurts when it's a name you love.
Draganfly to showcase drone, AI technology at World Police Summit 07:30 DPRO
DigitalOcean price target raised to $46 from $40 at Canaccord 07:28 DOCN
Generac downgraded to Neutral from Buy at Janney Montgomery Scott » 07:13 GNRC
Generac downgraded to Short Me from Hold at gummybear advisors
Generac downgraded to Hold from Buy at Truist 06:59 GNRC
Walmart: December was largest U.S. sales volume month in history
BioCryst sees 2023 ORLADEYO revenue no less than $320M 07:08 BCRX
Wells cuts SentinelOne to Equal Weight on concerns of declining demand trends » 06:50 S
Tesla driver fatally crashes into firetruck on interstate highway, WSJ reports 06:38 TSLA
Auto Pilot-?
Auto Pilot-?
Wingstop price target raised to $190 from $175 at Baird 06:38 WING
When my son was home we did a Wingstop Wing-out and it was pretty good!
For mass food anyway.
When my son was home we did a Wingstop Wing-out and it was pretty good!
For mass food anyway.
Well Joe T has been talking about entering Twillio. And today wouldbe the day. As i remember they had some vaguely good news last week?
Get this, the dapper Mr Mizuho who you know to be very consrvative announced this morning:
Twilio price target raised to $90 from $75 at Mizuho 06:37 TWLO
STOCK OF THE DAY TWILIO
Get this, the dapper Mr Mizuho who you know to be very consrvative announced this morning:
Twilio price target raised to $90 from $75 at Mizuho 06:37 TWLO
STOCK OF THE DAY TWILIO
Nice call when it's already down $4 on the bid.
Precient.
You missed the 50% run.
The readers took the profit at $135.
You're welcome!
General Mills raises FY23 adjusted EPS view to up 7%-8% from up 4%-6% 06:33 GIS
Yum!
Home Depot reports Q4 EPS $3.30, consensus $3.28
Not So Yum!
Yum!
Home Depot reports Q4 EPS $3.30, consensus $3.28
Not So Yum!
The children Stoney!Harmonic Inc. (HLIT)[/SIZE]
14.63+0.87 (+6.32%)<--------------
As of 03:36PM EST.
This dog isn't going anywhere, just like I said.
After the dust settles here... I think I'm 41-0 now.
And it's not even March yet.
FOCUS STOCK No.2-> VIR
Vir Biotechnology upgraded to Buy from Neutral at Goldman Sachs 04:35 VIR Goldman Sachs analyst Paul Choi upgraded Vir Biotechnology to Buy from Neutral with a price target of $53, up from $41. The company will report VIR-2482 data in mid-2023, which should show meaningfully better efficacy than currently approved and rival pipeline-stage flu vaccines and consequently to drive material upward revisions to consensus estimates, the analyst tells investors in a research note. Goldman sees a "compelling risk/reward" on shares of Vir into the day. It believes the readout represents "an underappreciated catalyst that could drive a major new leg of growth."
Vir Biotechnology upgraded to Buy from Neutral at Goldman Sachs 04:35 VIR Goldman Sachs analyst Paul Choi upgraded Vir Biotechnology to Buy from Neutral with a price target of $53, up from $41. The company will report VIR-2482 data in mid-2023, which should show meaningfully better efficacy than currently approved and rival pipeline-stage flu vaccines and consequently to drive material upward revisions to consensus estimates, the analyst tells investors in a research note. Goldman sees a "compelling risk/reward" on shares of Vir into the day. It believes the readout represents "an underappreciated catalyst that could drive a major new leg of growth."